Elevai Labs, Common Stock Current Valuation
| ELAB Stock | 2.49 0.08 3.11% |
Valuation analysis of Elevai Labs, Common helps investors to measure Elevai Labs,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of December 12, 2024, Enterprise Value Over EBITDA is expected to decline to -966.29. In addition to that, Enterprise Value Multiple is expected to decline to -966.29. Fundamental drivers impacting Elevai Labs,'s valuation include:
Price Book 0.9231 | Enterprise Value 130.6 K | Price Sales 3.193 | Enterprise Value Revenue 0.6438 |
Overvalued
Today
Please note that Elevai Labs,'s price fluctuation is abnormally volatile at this time. Calculation of the real value of Elevai Labs, Common is based on 3 months time horizon. Increasing Elevai Labs,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Elevai Labs, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elevai Stock. However, Elevai Labs,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.49 | Real 2.39 | Hype 1.95 |
The real value of Elevai Stock, also known as its intrinsic value, is the underlying worth of Elevai Labs, Common Company, which is reflected in its stock price. It is based on Elevai Labs,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Elevai Labs,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Elevai Labs, Common helps investors to forecast how Elevai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elevai Labs, more accurately as focusing exclusively on Elevai Labs,'s fundamentals will not take into account other important factors: Elevai Labs, Common Company Current Valuation Analysis
Elevai Labs,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Elevai Labs, Current Valuation | 130.64 K |
Most of Elevai Labs,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elevai Labs, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Elevai Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Elevai Labs, is extremely important. It helps to project a fair market value of Elevai Stock properly, considering its historical fundamentals such as Current Valuation. Since Elevai Labs,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elevai Labs,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elevai Labs,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Elevai Labs, Common has a Current Valuation of 130.64 K. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Elevai Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevai Labs,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevai Labs, could also be used in its relative valuation, which is a method of valuing Elevai Labs, by comparing valuation metrics of similar companies.Elevai Labs, is currently under evaluation in current valuation category among its peers.
Elevai Fundamentals
| Return On Equity | -3.51 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.92) % | ||||
| Operating Margin | (2.32) % | ||||
| Current Valuation | 130.64 K | ||||
| Shares Outstanding | 3.07 M | ||||
| Shares Owned By Insiders | 72.97 % | ||||
| Shares Owned By Institutions | 18.19 % | ||||
| Number Of Shares Shorted | 48.77 K | ||||
| Price To Book | 0.92 X | ||||
| Price To Sales | 3.19 X | ||||
| Revenue | 1.71 M | ||||
| EBITDA | (4.27 M) | ||||
| Net Income | (4.3 M) | ||||
| Total Debt | 210.49 K | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | (4.56 M) | ||||
| Short Ratio | 0.17 X | ||||
| Earnings Per Share | (88.92) X | ||||
| Number Of Employees | 18 | ||||
| Market Capitalization | 7.9 M | ||||
| Total Asset | 5.19 M | ||||
| Retained Earnings | (7.02 M) | ||||
| Working Capital | 3.62 M | ||||
| Net Asset | 5.19 M |
About Elevai Labs, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevai Labs, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevai Labs, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevai Labs, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Elevai Labs, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs, Common Stock:Check out Elevai Labs, Piotroski F Score and Elevai Labs, Altman Z Score analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (88.92) | Revenue Per Share 0.168 | Quarterly Revenue Growth 0.913 | Return On Assets (0.89) | Return On Equity (3.51) |
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.